Companies › Forus
Forus logo

Forus

New York, US · ≈184 employees · Information · Crunchbase rank #226 · forus.com

Forus is an AI-powered medication access platform that connects doctors, pharmacies, payers, and biopharmaceutical companies. The platform automates administrative steps between prescribing and treatment, including prior authorizations, benefit verification, appeals, enrollment forms, pharmacy routing, and financial assistance. It provides prescription tracking and patient communication throughout the medication access process. Forus integrates with electronic health record systems to support prescription and clinical information workflows. The platform supports medications covered through pharmacy and medical benefits, including specialty pharmacy and buy-and-bill therapies. It also provides tools for pharmaceutical companies to gain insight into medication access and patient treatment workflows. Forus is free for providers and patients and operates across the U.S. medication access system. The company was formerly known as Tandem and adopted the Forus name in May 2026.

Funding

2
Every round, secondary, debt facility or acquisition involving Forus that AI Lounge tracks, newest first. Latest: Series C on Sep 8, 2026.
Forus logo
Investors not disclosed · Health Care
$150M
Forus logo
Investors not disclosed · Health Care
$123M

Timeline · 4

Sep 8, 2026
Round
Sep 8, 2026
Deal
Jan 26, 2026
Round
Jan 26, 2026
Deal

In the news

2
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in